Axa S.A. Certara, Inc. Transaction History

Axa S.A.

$32.8 Billion
Q1 2024

A detailed history of Axa S.A. transactions in Certara, Inc. stock. As of the latest transaction made, Axa S.A. holds 216,776 shares of CERT stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

216,776

Previous 260,000 16.62%

Holding current value

$2.96 Million

Previous $4.57 Million 15.26%

% of portfolio

0.01%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$15.65 - $19.45 $676,455 - $840,706	-43,224 Reduced 16.62%	216,776 $3.88 Million
Q4 2023 Feb 14, 2024	SELL	$12.12 - $18.19 $603,576 - $905,862	-49,800 Reduced 16.07%	260,000 $4.57 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $19.58 $276,610 - $389,641	-19,900 Reduced 6.04%	309,800 $4.5 Million
Q2 2023 Aug 14, 2023	SELL	$16.89 - $24.64 $1.67 Million - $2.43 Million	-98,600 Reduced 23.02%	329,700 $6 Million
Q1 2023 May 15, 2023	BUY	$15.9 - $24.72 $2.36 Million - $3.67 Million	148,300 Added 52.96%	428,300 $10.3 Million

Q3 2022 Feb 14, 2023	BUY	$12.84 - $24.13 $770,400 - $1.45 Million	60,000 Added 27.27%	280,000 $3.72 Million
Q3 2022 Nov 14, 2022	BUY	$12.84 - $24.13 $770,400 - $1.45 Million	60,000 Added 27.27%	280,000 $3.72 Million
Q2 2022 Feb 14, 2023	BUY	$16.75 - $22.54 $354,631 - $477,216	21,172 Added 10.65%	220,000 $4.72 Million
Q2 2022 Aug 15, 2022	BUY	$16.75 - $22.54 $354,631 - $477,216	21,172 Added 10.65%	220,000 $4.72 Million
Q1 2022 Feb 14, 2023	SELL	$17.89 - $28.73 $1.45 Million - $2.33 Million	-81,172 Reduced 28.99%	198,828 $4.27 Million
Q3 2021 Nov 15, 2021	BUY	$24.46 - $38.41 $4.86 Million - $7.64 Million	198,828 New	198,828 $6.58 Million

Others Institutions Holding CERT

# of Institutions

225

Shares Held

109M

Call Options Held

7.8K

Put Options Held

View Full List

About Certara, Inc.

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $2.18B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

More about CERT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account